Nifty 17447.55 (1.58%)
Sensex 58596.43 (1.67%)
Nifty Bank 37279.5 (1.81%)
Nifty IT 35876.15 (1.71%)
Nifty Financial Services 18291.15 (1.73%)
Adani Ports 759.80 (2.03%)
Asian Paints 3106.00 (2.50%)
Axis Bank 697.40 (1.51%)
B P C L 391.10 (0.85%)
Bajaj Auto 3314.50 (0.85%)
Bajaj Finance 7333.95 (3.25%)
Bajaj Finserv 17622.00 (3.00%)
Bharti Airtel 715.70 (2.41%)
Britannia Inds. 3561.30 (2.51%)
Cipla 894.15 (0.55%)
Coal India 150.60 (-0.03%)
Divis Lab. 4604.05 (-0.45%)
Dr Reddys Labs 4577.80 (1.26%)
Eicher Motors 2488.90 (0.69%)
Grasim Inds 1716.90 (1.86%)
H D F C 2855.00 (1.33%)
HCL Technologies 1170.90 (1.85%)
HDFC Bank 1549.50 (1.56%)
HDFC Life Insur. 685.05 (-1.35%)
Hero Motocorp 2489.40 (1.12%)
Hind. Unilever 2333.30 (0.50%)
Hindalco Inds. 454.65 (2.75%)
I O C L 120.30 (-0.25%)
ICICI Bank 756.25 (2.94%)
IndusInd Bank 944.25 (1.90%)
Infosys 1747.85 (2.11%)
ITC 224.30 (1.65%)
JSW Steel 669.50 (1.34%)
Kotak Mah. Bank 1927.80 (-0.48%)
Larsen & Toubro 1831.45 (1.85%)
M & M 831.60 (0.68%)
Maruti Suzuki 7306.05 (1.66%)
Nestle India 19379.10 (0.18%)
NTPC 126.90 (1.24%)
O N G C 148.55 (1.82%)
Power Grid Corpn 205.10 (-0.34%)
Reliance Industr 2418.30 (1.53%)
SBI Life Insuran 1162.95 (0.33%)
Shree Cement 26222.90 (1.85%)
St Bk of India 489.80 (2.75%)
Sun Pharma.Inds. 753.00 (1.25%)
Tata Consumer 765.20 (0.59%)
Tata Motors 490.00 (1.70%)
Tata Steel 1171.70 (1.99%)
TCS 3625.05 (1.13%)
Tech Mahindra 1602.30 (1.63%)
Titan Company 2397.25 (0.70%)
UltraTech Cem. 7409.00 (1.50%)
UPL 730.70 (0.52%)
Wipro 642.20 (1.55%)
Dr. Reddy Laboratories and GAIL India Ltd Share Q2 Result
News - Updates
by 5paisa Research Team 29/10/2021

Dr. Reddy's Laboratories - Q2 Results


Dr. Reddy's Laboratories Ltd reported stellar numbers for the September 2021 quarter as its top line revenues grew by 17.7% at Rs.4,987 crore. Even on a quarter on quarter basis, the revenues were higher by 17.15%, showing even short term traction in the top line. Here is a gist of the key financials of Dr. Reddy Laboratories.

 

Rs in Crore

Sep-21

Sep-20

YOY

Jun-21

QOQ

Total Income (Rs cr)

₹ 5,763.20

₹ 4,896.70

17.70%

₹ 4,919.40

17.15%

Net Profit (Rs cr)

₹ 992.00

₹ 762.00

30.18%

₹ 571.00

73.73%

Diluted EPS (Rs)

₹ 59.65

₹ 45.83

 

₹ 34.34

 

Net Margins

17.21%

15.56%

 

11.61%

 


What were the triggers for the revenue growth. Let us look at specific verticals. Revenues from the pharma ingredients and the API segment were lower by 2.6% yoy at Rs.999 crore and that was due to supply chain constraints in the business. However, revenues from global generics were up 19% at Rs.4,743 crore and accounted for a bulk of the top line.

Net profits for the Sep-21 quarter were higher by 30.2% at Rs.992 crore. This was on the back of a spurt in the gross margins by 600 bps to 53.4%. Reddy Labs spent Rs.446 crore on  R&D which is 7.7% of sales, and well above the peer group median. EBITDA margins at 27% improved by 600 bps quarter on quarter. India and EM markets showed best growth.

Reddy Labs had a comfortable net debt to equity ratio of 0.015X. Free cash flows stood at Rs.83 crore, which can considered small for a company of that size and scale. Net margins for Reddy Labs at 17.21% was surely better than 15.56% in the Sep-20 year ago quarter and it was sharply better than NPM of 11.6% in Jun-21 quarter.
 

GAIL India Ltd - Q2 Results


India’s largest gas transportation company, GAIL India, reported 67.39% growth in total revenues for the Sep-21 quarter on consolidated basis at Rs21,782cr. The revenues were higher by 73% on a sequential basis compared to Rs17,589cr revenues in the Jun-21 quarter. There was a volume boost and also a price boost linked to crude oil prices.

 

Rs in Crore

Sep-21

Sep-20

YOY

Jun-21

QOQ

Total Income (Rs cr)

₹ 21,782

₹ 13,012

67.39%

₹ 17,589

23.84%

Net Profit (Rs cr)

₹ 2,883

₹ 1,112

159.34%

₹ 2,138

34.88%

Diluted EPS (Rs)

₹ 6.49

₹ 2.47

 

₹ 4.81

 

Net Margins

13.24%

8.54%

 

12.15%

 

 

In terms of verticals of GAIL, the major boost to revenues came from the natural gas marketing vertical which was up by 71% at Rs21,011cr. Two other verticals viz.  natural gas transmission and LPG transmission was almost flat on YoY basis. However petchem, liquid hydrocarbons and the CGD business saw good growth in revenues on YoY basis.

Net profits were up 159.34% for the Sep-21 quarter at Rs.2,883 crore. Profits were also higher by 35% on a quarter to quarter basis. The big boost to EBIT came from natural gas marketing which went from an EBIT loss of Rs-335 crore to an EBIT profit of Rs.1,029 crore. That actually triggered the boost to the overall profits to GAIL.

The EBIT contributions of CGD, liquid hydrocarbons and petchem also showed growth like in the case of the top line. However, this was on a much lower base. Net profit margins at 13.24% was substantially superior to 8.54% in the Sep-20 quarter and was also better than the net profit margins of 12.15% in Jun-21 quarter.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Start Investing Now!

Open Free Demat Account in 5 mins

 
 
There is some issue, try later